Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
jRCTs072240080Completed
Open-label trial of Anespatch in gingival disease (2 arms), sponsored by CosMED Pharmaceutical. Primary endpoint: Pain during local anesthesia. Started Nov 2024; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on jRCTs072240080.